The surprisingly long dry spell should serve as a warning to New England policy makers that the days of cheap, plentiful, low-carbon power from the north hitting the spot market are no longer guaranteed.
For those who know Pritzker, the senior fellow of the Harvard Corporation, it is no surprise that the 66-year-old Chicago billionaire wants the university to fight back, even if the costs are steep.
Thursday night’s dinner for the 220 biggest investors in the $TRUMP meme coin has raised uncomfortable questions about potentially shadowy buyers using the anonymity of the internet to buy access to the president.
The winding series of Senate procedural votes that went late into the evening could have profound implications for California’s longstanding efforts to reduce air pollution.
Robert F. Kennedy Jr. is questioning vaccines and the Food and Drug Administration just set a higher bar for COVID booster approvals, but Rhode Island-based CVS Health Corp. is pushing hard to make sure people get their shots.
The Cambridge-based biotech company said it made the decision after consulting with the Food and Drug Administration. It plans to resubmit the application later this year after getting more data from a late-stage trial of its standalone flu vaccine.
